BMCP: advanced mass spectrometry to identify macromolecules
Project fact sheet
BMCP
Vertical: Personalised health
Project description
The project seeks to develop an advanced mass spectrometry detector (BMCP). Its technology – protection sought in a patent application – is based on integrating a Si3N4 nanomembrane (NM) in detection mechatronics (own software) within a MCP (microchannel plate), able to precisely and reliably identify macromolecules, proteins and molecular high mass conglomerations in the mass spectrometry equipment.
The project has attracted interest from an international industrial corporation, and a leading player in the personalised health sector.
Market
Research laboratories, pharmaceuticals, food safety test facilities, biotechnology companies, and clinical diagnosis laboratories, inter alia.
Technology tags
Business model
Project needs
Promoted by
Are you interested in high-tech projects capable of generating greater market impact?
Fill in this form and we will contact you if you want to take part in this initiative – either by contributing technology assets or if you are a talent promoter capable of turning them into business projects.
Related news
NeoSegMed: AI-powered software for biomedical image segmentation and implant planning
Basque Tek Ventures supports the work behind NeoSegMed, an AI software solution that transforms biomedical images into 3D models and helps plan dental implants and personalized surgical guides.
SORPMETRICS: We make adsorption visible
Basque Tek Ventures supports Sorpmetrics, a project developing devices that directly measure how much of a substance a porous material captures from a liquid, without destroying the sample.
XRAI: Cost and environmental impact reduction by decreasing the number of false defects through the use of AI in inspections
Basque Tek Ventures supports XRAI in applying AI to industrial inspection to classify defects detected in parts and reduce the manual review of potential non-conformities.
BIOND: Biomimetic Bioreactors for Cell Culture
Basque Tek Ventures supports BIOND's project which combines biochemical and biophysical stimuli to study cell behavior with unprecedented realism, accelerating drug discovery and enabling more effective, personalized treatments for each patient.
BACKPACKED-ANTIBODIES: increasing the therapeutic payload and improves efficacy and tolerability compared to ADCs
Basque Tek Ventures supports B-Ab’s project, which develops an antibody platform with lipid nanodiscs to carry larger therapeutic payloads and combine different drugs.
HEVEA 3D: 3D printing of real elastomers without moulds: functional parts in a matter of days
Basque Tek Ventures supports Hevea3D’s project, which produces functional elastomeric parts through latex 3D printing, without the need for molds and with shorter development times.
FURANTEK: Cost-effective and scalable bio-based PDO to capture a high-value chemical market
Basque Tek Ventures supports this initiative, which develops cost-effective, scalable bio-based PDO technology to capture a high-value chemical market.
SEBALEX THERAPEUTICS: Therapeutic antibodies for prostate cancer and pulmonary fibrosis
Basque Tek Ventures supports SebAleX Therapeutics’ project, which develops antibodies targeting WNT11 with the potential to treat certain types of cancer and fibrotic diseases.
NOVANANO MEDICAL: Implant modification to prevent the formation of bacterial biofilms
Basque Tek Ventures supports Novanano Medical’s project, which develops nanoscale surface treatments and coatings for medical implants, reducing bacterial adhesion and promoting implant integration with surrounding tissues.
BIOBLUE: The next generation of biodegradable FADs for tuna fishing
Bioblue’s project develops fish aggregating devices for tuna fishing using bio-based and biodegradable materials that remain functional during use and degrade in the sea.